ArticlePathogens (Basel, Switzerland)2021
Emergence of IncHI2 Plasmid-Harboring blaNDM-5 from Porcine
Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Genomic characterization of an extensively drug-resistant Klebsiella pneumoniae co-harboring mcr-3.11, blaNDM-5 and blaCTX-M-27 isolated from pelvic effusion in a colon cancer patient.BMC microbiology · 2026Article
- Genomic landscape ofApplied and environmental microbiology · 2026Article
- The postantibiotic effect-like effect of photothermal agents: evidence from IR780 nanoparticles and indocyanine green.Frontiers in pharmacology · 2026Article
- Genome Characteristic of NDM-5-ProducingInfection and drug resistance · 2025Article
- Rapid Dissemination ofPathogens (Basel, Switzerland) · 2024Article
- Genomic Characterization of a Plasmid-Free and Highly Drug-ResistantVeterinary sciences · 2024Article
- Emergence of aInfection and drug resistance · 2024Article
- Article
- Genetic and enzymatic characterization of two novel blaEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023Article
- Molecular surveillance reveals the emergence and dissemination of NDM-5-producingEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Article
- Characterization of NDM-5-ProducingGenes · 2023Article
- Occurrence and characterization of NDM-5-producingFrontiers in microbiology · 2023Article
- Characterization of NDM-5-producingZoological research · 2022Article
- Emergence of a High-RiskFrontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbapenem resistance has posed potential harmful risks to human and animals. The objectives of this study were to understand the prevalence of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.